Merck (MRK) Tops Q2 EPS by 33c, Updates FY Guidance

July 31, 2020 6:46 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Merck (NYSE: MRK) reported Q2 EPS of $1.37, $0.33 better than the analyst estimate of $1.04. Revenue for the quarter came in at $10.9 billion versus the consensus estimate of $10.39 billion.


Merck sees FY2020 EPS of $5.63-$5.78, versus the consensus of $5.31. Merck sees FY2020 revenue of $47.2-48.7 billion, versus the consensus of $47.3 billion.

For earnings history and earnings-related data on Merck (MRK) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings

Related Entities